TGA warns against advertising mLs and units pricing
12 Aug 2019
The Therapeutic Goods Administration (TGA) has warned doctors against advertising a price per ‘units’ or ‘mLs’ for cosmetic injections.
The warnings came in letters sent to individual doctors following complaints made to the TGA. The letters stated that such pricing “makes an indirect reference to a Schedule 4 (Prescription Only) substance as it is not possible to purchase units of a service”.
The letter further stated:
“Advertisements for cosmetic services MUST NOT specify trade names of products (e.g., Belkyra) containing Schedule 4 substances or ingredients (e.g., deoxycholic acid) that are Schedule 4 substances, or make indirect reference to Schedule 4 substances from which they can be identified as this is a breach of the Act.”
Guidance on legal obligations when advertising therapeutic goods can be found on the TGA’s advertising hub.
Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Reportable Deaths and Coronial Matters
MDA National's Daniel Spencer (Case Manager - Solicitor) and Karen Lam (Medico-Legal Adviser) discuss when a person's death should be reported to the Coroner and what to do if the Coroner requests a statement or report.
15 May 2025
Death Certificates
When a doctor can write a death certificate (where the death does not need to be reported to the Coroner), considerations when writing the death certificate and how to complete it accurately.
15 May 2025
Communication in healthcare teams
Why good and effective communication is a vital part of delivering quality and safe patient care
15 May 2025
Doctors, Let's Talk: Setting Boundaries At Work
A conversation with Nicola Campbell, Psychiatry Registrar, that explores the necessity of setting professional boundaries as a Junior Doctor.
07 Dec 2022
